Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study

Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study

Abstract Background Non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine kinase inhibitors (TKIs) has shown the effectiveness; however, knowledge of the clinical factors associated with ou...

Full description

Bibliographic Details
Main Authors: Yung-Hsuan Chen, Yen-Fu Chen, Chung-Yu Chen, Jin-Yuan Shih, Chong-Jen Yu
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Cancer
Subjects:
NSCLC
EGFR-TKI
Brain metastasis
Brain radiotherapy
Uncommon mutations
Online Access:http://link.springer.com/article/10.1186/s12885-019-6140-0

Internet

http://link.springer.com/article/10.1186/s12885-019-6140-0

Similar Items